Re: Ulander et al.: Side effects to continuous positive airway pressure treatment for obstructive sleep apnoea: changes over time and association to adherence.
Dear Editor:We read with interest the article by Ulander et al. entitled, "Side effects of continuous positive airway pressure treatment for obstructive sleep apnea: Changes over time and association to adherence" [1]. The authors summarized the incidence of side effects to continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) over 12 months of therapy.We query what Ulander and colleagues mean as "eye irritation." How was this condition identified in patients? Did the investigators use an objective scale such as Ocular Surface Disease Index questionnaire (OSDI) [2]? It is well accepted that the OSDI is a valid and reliable instrument for measuring and following the severity and of ocular surface disease. We recommend that the OSDI be used for all ocular surface assessments.We also question whether or not ophthalmologic examination of these patients was performed before initiation of CPAP therapy. To detect the effects of some systemic diseases on the ocular surface in this study, patients should have been examined for abnormalities of skin, joints, and endocrinology system before beginning CPAP therapy. Were there any topical drugs used for ocular disease? We believe that the ocular assessment may be incomplete if these questions are not properly addressed.Ulander and coauthors found that eye irritation in patients after the first 1-2 weeks of CPAP use was 9.2 %, 8.5 % at 3-6 months, and 17 % at 9-12 months. In a recently published article entitled "Ocular surface assessment in patients with obstructive sleep apnea hypopnea syndrome" [3], we reported that the shortened tear film break-up times, reduction in Schirmer test results and high levels of OSDI scores in the severe disease group correlated with Apnea-Hypopnea Index (AHI). In a second article entitled "Long-term effects of PAP on ocular surface in obstructive sleep apnea syndrome" [4], we observed a decrease in the OSDI scores in 51 patients with OSA, following PAP therapy for a period of 18 months. We conjecture that a decrease of the OSDI scores was associated with healing of eyelid ischemia, floppy eyelid syndrome (FES), tear function tests, and improvement of overall health of the ocular surface with CPAP therapy.In conclusion, we believe that appropriate use of long-term use CPAP therapy improves the clinical picture of ocular health and can overcome the problem of ocular irritation that is encountered in the early stages of CPAP therapy.
Conflict of interest NoneReferences 1. Ulander M, Johansson MS, Ewaldh AE, Svanborg E, Broström A (2014) Side effects to continuous positive airway pressure treatment for obstructive sleep apnoea: changes over time and association to adherence. Sleep Breath 18:799-807 2. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the Ocular Surface Disease Index.